Difficulty: Medium
Average Score: 90%
Practice
A client receiving high-dose chemotherapy who has bone marrow suppression has been receiving daily injections of epoetin alfa (Procrit). Which assessment finding indicates to the nurse that today's dose should be held and the health care provider notified?
Correct answer
C
Rationale
The correct answer is C. A significant blood pressure change from $130 / 90 \mathrm{~mm} \mathrm{Hg}$ to $148 / 98 \mathrm{~mm} \mathrm{Hg}$ indicates a potential hypertensive crisis which could be a serious adverse effect of epoetin alfa. Holding the dose and notifying the healthcare provider is crucial to prevent further complications.
A: A hematocrit of $28 \%$ is low but expected in bone marrow suppression and is not an immediate concern.
B: A total white blood cell count of 6200 cells $/ \mathrm{mm} 3$ is within normal range and not a reason to hold the dose.
D: A temperature change from $99^{\circ} \mathrm{F}$ to $100 \mathrm{~F}$ is a mild elevation and not directly related to epoetin alfa administration.
A: A hematocrit of $28 \%$ is low but expected in bone marrow suppression and is not an immediate concern.
B: A total white blood cell count of 6200 cells $/ \mathrm{mm} 3$ is within normal range and not a reason to hold the dose.
D: A temperature change from $99^{\circ} \mathrm{F}$ to $100 \mathrm{~F}$ is a mild elevation and not directly related to epoetin alfa administration.